Jtc Employer Solutions Trustee LTD Recursion Pharmaceuticals, Inc. Transaction History
Jtc Employer Solutions Trustee LTD
- $1.22 Billion
- Q1 2025
A detailed history of Jtc Employer Solutions Trustee LTD transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Jtc Employer Solutions Trustee LTD holds 2,392 shares of RXRX stock, worth $11,960. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,392
Previous 2,392
-0.0%
Holding current value
$11,960
Previous $16,000
18.75%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
365Shares Held
286MCall Options Held
3.28MPut Options Held
3.16M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl34.8MShares$174 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.3MShares$161 Million0.0% of portfolio
-
Baillie Gifford & CO24.4MShares$122 Million0.12% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$86.6 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$73.3 Million0.27% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $902M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...